Lung Cancer

Top Story

FDA expands approval of Gilotrif for advanced lung cancer with uncommon EGFR mutations

FDA expands approval of Gilotrif for advanced lung cancer with uncommon <i>EGFR</i> mutations
January 15, 2018

The Wistar Institute marks 125 years of research milestones for cancer, infectious diseases

January 12, 2018
The Wistar Institute in Philadelphia recently celebrated its 125th anniversary. Established in 1892, the institute is the first NCI-designated basic research center in…
In the Journals Plus

Toxic effects of immunotherapy ‘a valid concern’ among oncology experts

January 11, 2018
Combining nivolumab with epidermal growth factor receptor tyrosine kinase inhibitors increased the risk for
In the Journals Plus

Most older patients with advanced lung cancer receive no therapy

January 8, 2018
A majority of patients with stage III lung cancer aged older than 80 years received no cancer-directed therapy, according to study results published in Cancer. Further…
More Headlines »
CME ABIM MOC

Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass

There is no commercial support for this activity.

This “Ace the Case” activity will discuss the diagnosis and management of a 70-year-old woman with cough…
More »
Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium